Obesity and vitamin D deficiency have both been recognized as major public health issues worldwide, and there is growing evidence that they are related, although the cause-effect relationship remains unclear. Could obesity be contributing to low circulating 25-hydroxyvitamin D concentrations? Alternatively, could low vitamin D status predispose to obesity? In this review, the relationship between low circulating 25-hydroxyvitamin D and obesity, and possible underlying reasons from both perspectives, is presented. One potential mechanism by which obesity could contribute to low serum 25-hydroxyvitamin D is adipose sequestration of vitamin D. On the other hand, adipose tissue has both the vitamin D receptor and the ability to synthesize 1,25-dihydroxyvitamin D, and there is evidence that vitamin D may regulate adipose tissue mass, differentiation and metabolism in ways that might contribute to obesity. Of particular interest, vitamin D deficiency is common both before and after bariatric surgery, and is often difficult to treat, particularly with the more malabsorptive procedures. Additional research is needed to elucidate the complex and multifaceted factors underlying the association between low circulating 25-hydroxyvitamin D and obesity, and to identify optimal treatment approaches in obese individuals and in bariatric surgical patients both before and after surgery.
Introduction
Obesity is well-recognized as a global epidemic 1 and is associated with various co-morbidities, including hypertension, insulin resistance and other components of the metabolic syndrome. 2, 3 Obesity and these related issues contribute significantly to modern healthcare costs, morbidity and mortality. 4, 5 Furthermore, weight loss is difficult to achieve and sustain, and consequently many individuals, especially those who already have significant co-morbidities, are turning to bariatric weight loss surgery as a way to effectively treat obesity. 6 Vitamin D deficiency has also been identified as a worldwide public health issue. 7 The Institute of Medicine currently defines vitamin D deficiency as serum 25-hydroxyvitamin D concentration o20 ng dl À1 or o50 nmol l
À1
. 8 Recent studies have opened up a new dimension regarding the relevance of vitamin D in health. Vitamin D has been suggested to be a potential factor in the prevention of many illnesses, including some cancers, autoimmune disorders, hypertension, diabetes 2,9-14 and, even more speculatively, perhaps obesity itself. 12 In this review, we will focus on the relationship between vitamin D deficiency and obesity in adults, including a discussion of potential underlying reasons for the strong association between these two modern health issues. We will also highlight bariatric weight loss as an example of a situation associated with high risk for vitamin D deficiency. Notably, bariatric patients are not only at increased risk before surgery, but they are often quite difficult to treat for vitamin D deficiency post-operatively, and we will discuss underlying contributors to this problem.
Materials and methods
A search of the literature using Ovid Medline was performed using the following search terms: (obesity OR bariatric surgery OR adipose) AND (vitamin D It has been well-observed that obese individuals frequently have below normal circulating 25-hydroxyvitamin D. There are two perspectives from which to view this relationship, and there is limited evidence to support both. First, the condition of obesity might be driving low serum 25-hydroxyvitamin D concentrations. On the other hand, it is possible that low circulating 25-hydroxyvitamin D itself may, at least in some circumstances, contribute to obesity or inhibit weight loss. We will begin with some general observations from both in vitro and human studies that suggest a link between obesity and low serum vitamin D concentrations. A thorough review of the relevant literature exploring the potential cause-effect relationships between these two important public health issues will follow.
In vitro studies show that the VDR and 1-a-hydroxylase enzyme are present in adipose tissue It is now known that a number of non-renal tissues, including adipose, have both the nuclear vitamin D recepter (VDR) and the ability to synthesize 1,25-dihydroxyvitamin D through the 25-hydroxyvitamin D-1-a-hydroxylase enzyme, which can account for many of the emerging non-traditional roles of vitamin D throughout the body. 15, 16 Kamei et al.
17
were some of the first to observe that 3T3-L1 pre-adipocytes express the VDR. Querfeld et al. 18 Various investigators have suggested additional potential reasons for obesity as a contributor to decreased circulating 25-hydroxyvitamin D. One hypothesis is that there may be increased catabolism of vitamin D with increasing adiposity owing to the local action of the 24-hydroxylase enzyme that has been found in human adipose tissue. 19 Another hypothesis is that synthesis of 25-hydroxyvitamin D by the liver may occur at a lower rate in obese individuals relative to that in lean individuals. Obesity is associated with nonalcoholic fatty liver disease, and it has been observed that individuals with non-alcoholic fatty liver disease (n ¼ 60) had significantly reduced winter serum 25-hydroxyvitamin D concentrations as compared with that in healthy, weightmatched controls (n ¼ 60). 67 Furthermore, serum 25-hydroxyvitamin D concentration was inversely associated with the degree of histological severity of hepatic steatosis, fibrosis and inflammation in the non-alcoholic fatty liver disease patients in this study, 67 suggesting that, perhaps the deranged activity of the liver may lead to a reduction in the 25-hydroxylation of vitamin D, leading to a decrease in the serum 25-hydroxyvitamin D concentrations. It has also been proposed that obese individuals are less exposed to sunlight, leading to deficiency, potentially because of less involvement in outdoor activities and clothing habits resulting in less skin exposure. 68 Indeed, a recent report found that obese individuals who exercise outdoors are 47% less likely to be vitamin D deficient than those who do not. 69 Yet an additional question that has been posed is, whether total-body clearance of vitamin D could be increased during obesity-associated inflammation, 39 and in vitro studies have
shown that active vitamin D may have an anti-inflammatory effect. 70 There are limited in vivo data relevant to this discussion in obese individuals. Visceral adiposity in particular is associated with inflammation, 71, 72 and serum 25-hydroxyvitamin D has been observed to be inversely related to visceral adiposity in African-Americans. 52 The proinflammatory state has been linked to risk for atherosclerosis, and several recent studies have investigated the potential role of vitamin D in outcomes related to cardiovascular disease. For example, a study of normal-weight, healthy Turkish men and women reported that vitamin D deficiency was
The link between obesity and low 25OH vitamin D CP Earthman et al associated with endothelial dysfunction and lipid peroxidation, and thus may be considered to be an independent risk factor for atherosclerosis; vitamin D repletion was associated with improvements in endothelial function. 73 Oh et al. The link between obesity and low 25OH vitamin D CP Earthman et al concentrations but had no apparent effect on energy expenditure or gene expression (mRNA) of the proteins and enzymes involved in lipogenesis or lipolysis, including uncoupling protein-2, fatty acid synthase, glycerol phosphate dehydrogenase-2, hormone-sensitive lipase or PPAR-g when baseline subcutaneous adipose tissue biopsy levels were compared with those of samples obtained 7 days later. 88 However, treatment duration and dose may not have been adequate to see significant effects on these parameters; gene expression may not mirror protein expression; and there could also potentially be depot-specific responses to local vitamin D concentrations. In summary, basic studies are inconclusive in determining what, if any, significant role vitamin D might have in relation to adiposity. Additional properly designed experiments that accurately mirror human physiology should be conducted with vitamin D exposure at physiological concentrations in order to further elucidate this issue. Indeed, given that adipose tissue has 1-a-hydroxlase activity, it is possible that physiological tissue and intracellular concentrations of 1,25-hydroxyvitamin D levels may differ significantly from circulating levels, and that small differences in the level of this hormonal form of vitamin D may lead to significant alterations in local effects on adiposity. Additionally, further knockout models will also be important for enhancing our understanding of the role of vitamin D in fat mass regulation.
Effects of vitamin D status on weight loss success in human clinical research studies. Some investigators suggest that vitamin D has antiobesogenic effects because it has been observed that vitamin D status is associated with weight loss success. Specifically, there have been a small number of human clinical studies in which an association between baseline vitamin D status and subsequent weight loss success was identified. For example, Ljunghall et al. 89 reported, as a secondary finding in a study designed to investigate the effect of vitamin D supplementation on insulin secretion, that subjects who received low-dose vitamin D (cholecalciferol) supplementation showed a small but significant loss of body weight as compared with subjects receiving placebo. Ortega et al. 90 observed in a hypo-caloric weight loss intervention study that baseline serum 25-hydroxyvitamin D was a strong predictor of weight loss. In this study, women with higher baseline serum 25-hydroxyvitamin D concentrations experienced a greater degree of successful weight loss than women who had lower baseline serum vitamin D, despite having similar energy intakes. Teegarden et al. 91 also conducted a hypo-caloric weight loss intervention trial, and they reported that in overweight and obese women on a 500-kcal day À1 deficit, baseline serum 25-hydroxyvitamin D concentration was a strong positive predictor of change in the thermic effect of a meal after 12 weeks of the diet: for example, the higher the baseline vitamin D concentration, the greater the thermic effect of food observed after meals. 94 also did not find an effect of baseline vitamin D status on subsequent weight loss. These investigators did state that they were using a weight loss strategy; however, they did not provide sufficient details about the specific weight loss intervention to ascertain if a systematic hypo-caloric diet approach was taken, and they did not specify if an exercise intervention was included in the treatment protocol. Thus, it is possible that the effect that vitamin D has on adiposity may depend on other factors such as whether or not a hypo-caloric diet is being attempted, or what the vitamin D status is at the time of weight loss diet initiation, or perhaps some other factor closely related to vitamin D status such as PTH, as will be discussed below.
Could some other factor linked with low vitamin D status be a contributing causal factor in the low vitamin D status-obesity relationship? Some investigators have suggested that it is not specifically low vitamin D status, but some other factor closely linked to low vitamin D status, such as elevated PTH, which promotes obesity and inhibits weight loss. 95 It has been proposed that PTH inhibits lipolysis. 18, 95 Others have proposed that low calcium status, which would be linked with low vitamin D status, is a contributor to the inability to lose weight, and thus high-calcium diets may help with weight loss by repleting calcium. 96, 97 This hypothesis is controversial and studies of high-calcium diets have reported variable effects on weight loss. Holecki et al. 98 reported that supplementation with calcium (2000 mg day
À1
) and cholecalciferol (1000 IU day À1 ) in individuals on a hypo-caloric weight loss regimen had no effect on weight or fat loss as compared with unsupplemented controls. By contrast, Shahar et al. 99 reported recently that 6-month serum 25-hydroxyvitamin D concentrations and dairy calcium intake were associated with subsequent weight loss at 2 years in a study of 126 men and women on three different non-calorically restricted dietary regimens. Still others have hypothesized that low vitamin D status triggers a 'winter' response, a kind of hibernation state characterized by a lower metabolic rate. 12 In summary, studies to date are inconclusive as to what effect vitamin D might have on adiposity, with some
The link between obesity and low 25OH vitamin D CP Earthman et al suggesting that weight/fat loss would be promoted, and others indicating that weight/fat loss would be inhibited and/or weight gain would be promoted by vitamin D. Clearly, the vitamin D-obesity relationship is not well understood yet, and there could be many factors influencing it, both directly and indirectly. Additional research is needed to elucidate the complex and multifaceted factors underlying the observed association between low vitamin D status and obesity.
Bariatric weight loss surgical patients: a special population with impaired vitamin D status Bariatric surgery further complicates attempts to achieve adequate vitamin D status. The anatomic changes that occur with bariatric surgery can lead to challenges in optimizing postoperative vitamin D status. Vitamin D absorption is dependent on micellar solubilization within chylomicrons, with the most rapid absorption rate in the jejunum. However, given the longer transit time in the distal ileum, significant absorption also occurs there. 105, 106 Vitamin D absorbed from the gastrointestinal tract enters circulation through the lymphatic circulation and the thoracic duct.
106
Given the physiology involved with oral vitamin D absorption, malabsorptive procedures such as the biliopancreatic diversion make vitamin D repletion and maintenance even more challenging. 37 Even the RYGB, which is not considered to be a purely malabsorptive procedure, but incorporates both restrictive and malabsorptive elements, presents challenges for vitamin D repletion, given that variable characteristics such as limb length can affect absorption. 24 There are limited data on how best to treat low vitamin D status in bariatric surgery patients, and procedure-specific . Thirty-two out of the 40 subjects who were followed at 6 months after surgery met the definition of low vitamin D status; 17 out of the 32 subjects responded to treatment (94% compliance), with serum 25-hydroxyvitamin D concentrations increasing to an average of 42 ng ml
À1
. The 15 subjects who did not respond to treatment also had good compliance to the high-dose regimen (86%), and it was unclear why they did not respond. Clearly, additional research is needed in order to establish evidence-based (and potentially procedure-specific) guidelines on optimal treatment of low vitamin D status following bariatric surgery.
The 2010 National Osteoporosis guidelines suggest the following for vitamin D-related optimization in this population: Monitoring of serum calcium, PTH and 25-hydroxyvitamin D every 3-4 months initially to achieve optimal levels (at least 30-50 ng ml À1 (75-125 nmol l
) with normalized PTH), with monitoring every 6-12 months thereafter to make sure optimal levels are maintained. 108 Further research is needed to more fully understand the physiological alterations to the PTH-vitamin D system seen in obese individuals before surgery; to more carefully define the impact of specific surgical factors on vitamin D status; and to optimize treatment approaches after surgery in this ever increasing clinical population.
Summary and conclusion
Various epidemiological studies and clinical trials show that obese individuals have low serum concentrations of 25-hydoxyvitamin D. This observed relationship between low vitamin D status and obesity may be because of mechanisms such as adipose sequestration. By contrast, low serum 25-hydroxyvitamin D could potentially contribute to obesity by effects on lipogenesis and/or adipogenesis that may occur in adipose tissue. In this review, we have summarized potential cause-effect relationships that may underlie this link. Additional studies are needed to understand the vitamin D physiology in adipose, and the relationship between obesity and low vitamin D status. Follow-up cell culture and animal model studies are needed, with ultimate translation into human studies. Clinical studies to determine optimal treatment guidelines are needed for surgical and non-surgical populations with obesity. Key questions that remain to be answered include the following:
(1) Why is obesity associated with low vitamin D status? (2) What is the 'optimal' oral supplemental dose of vitamin D (taking into account all sources, including UVB exposure and dietary intake) in severely obese individuals, both before and after bariatric surgery? In conclusion, in this review the relationship between low circulating 25-hydroxyvitamin D and obesity was discussed, including potential mechanisms through which each might impact the other. Regardless of the ultimate cause-effect balance in this relationship, treatment of low vitamin D status in individuals with obesity could have a large public health impact on a number of modern health issues, and thus, the questions posed here are both timely and important.
